GLP-1 & Metabolic Research Peptides

GLP-1 and metabolic research peptides for sale

This category covers incretin-pathway and metabolic research compounds: single GLP-1 receptor agonists such as Semaglutide and Liraglutide; the dual GIP/GLP-1 agonist Tirzepatide; the triple GIP/GLP-1/glucagon agonist Retatrutide; amylin analogues including Cagrilintide and CagriSema; and newer candidates like Mazdutide, Survodutide and the small-molecule Orforglipron.

In published research these compounds are used to study glucose-dependent insulin secretion, gastric emptying, appetite signalling and energy balance. For a side-by-side view of receptor targets and half-lives, read the GLP-1 comparison, the Semaglutide vs Retatrutide review and the Tirzepatide research guide.

Buying GLP-1 research peptides online

Each product lists its HPLC purity specification (≥98% or higher). Where a CertikLabs certificate of analysis (COA) is available for a strength and lot, it is linked from that product page with HPLC purity, LC-MS identity, and concentration results. For long, lipidated GLP-1 analogues, LC-MS supports molecular identity while HPLC characterizes chromatographic purity; purity and identity are not interchangeable. All compounds are supplied lyophilized, strictly for in-vitro laboratory research. They are not drugs, supplements or cosmetics and are not for human or veterinary use — see Research Use Only.

Frequently asked questions

What is the difference between Semaglutide, Tirzepatide and Retatrutide?

Semaglutide activates the GLP-1 receptor; Tirzepatide activates both GIP and GLP-1 receptors; Retatrutide activates GIP, GLP-1 and glucagon receptors. Our GLP-1 comparison guide summarises the published data.

Are these GLP-1 peptides for weight loss use?

No. They are sold strictly as research compounds for laboratory study and are not for human use.